[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370938-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370938-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","roles-of-neutrophils-in-autoimmune-diseases-and-cancers","Roles of Neutrophils in Autoimmune Diseases and Cancers","","Neutrophils act as first-line defenders with multifaceted roles in chronic inflammation, autoimmune pathology, and cancer progression. Microenvironmental signals drive functional plasticity and phenotypic heterogeneity, enabling neutrophils to contribute to both protection and disease. In autoimmune disorders such as SLE, RA, and JIA, dysregulated low-density granulocytes promote inflammation, NETosis, and type I interferon-mediated signaling, causing tissue injury. In tumors, tumor-associated neutrophils can polarize into N1 or N2 phenotypes depending on factors like TGF-β and epigenetic regulators. Progress in neutrophil biology supports therapeutic strategies including NET targeting, CXCR2 inhibition, and neutrophil-derived biomarkers for diagnosis and monitoring.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/roles-of-neutrophils-in-autoimmune-diseases-and-cancers/370938/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/roles-of-neutrophils-in-autoimmune-diseases-and-cancers/370938.png","ImageObject",300,407,{"name":42,"@type":43},"Mary Man","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do neutrophils contribute to autoimmune disease pathology?","Question",{"text":63,"@type":64},"Autoimmune diseases such as SLE, RA, and JIA involve dysregulated neutrophil subsets, including low-density granulocytes that promote proinflammation and tissue damage through NETosis and type I interferon-mediated signaling.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the role of neutrophils in cancer progression?",{"text":68,"@type":64},"In tumors, tumor-associated neutrophils (TANs) can polarize toward anti-tumorigenic N1 or pro-tumorigenic N2 phenotypes, influenced by modulators such as TGF-β and leucine-driven epigenetic modifications.",{"name":70,"@type":61,"acceptedAnswer":71},"What therapeutic directions does the neutrophil research support?",{"text":72,"@type":64},"Therapeutic strategies include targeting NETs, inhibiting chemokine receptors such as CXCR2, and using neutrophil-derived biomarkers for diagnosis and disease monitoring.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370938,1790240080,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nRoles of Neutrophils in Autoimmune Diseases and Cancers  \nAnjali Bhargav 1, Vinay Kumar 2 and Neeraj Kumar Rai 3, *  \nAcademic Editor: Rachel Shukrun  \nReceived: 25 July 2025  \nRevised: 3 September 2025  \nAccepted: 16 September 2025  \nPublished: 17 September 2025  \nCitation: Bhargav, A.; Kumar, V.; Rai, N.K. Roles of Neutrophils in Autoimmune Diseases and Cancers. Int. J. Mol. Sci. 2025, 26, 9040. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26189040](doi.org/10.3390/ijms26189040)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow 226014, India; [anjbhargav@gmail.com](anjbhargav@gmail.com)  \n2 Hershey Medical Center, Heart and Vascular Institute, Pennsylvania State University, Hershey, PA 17033, USA; [vinayktyagi07@gmail.com](vinayktyagi07@gmail.com)  \n3 Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT 84112, USA  \n* [Correspondence: neerajrai2601@gmail.com](Correspondence: neerajrai2601@gmail.com)  \nAbstract  \nNeutrophils, a first-line defender, has a multifaceted presence in chronic inflammation, autoimmune pathology, and tumor progression. The microenvironmental cues facilitate functional plasticity and phenotypic heterogeneity to neutrophils that enable both their protective and pathogenic roles. Autoimmune diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and juvenile idiopathic arthritis (JIA) display the presence of dysregulated subsets of neutrophil, such as low-density granulocytes (LDGs) that promote proinflammation and contribute to tissue damage via NETosis and type I interferon-mediated signaling. In cancer, particularly tumors, they exhibit tumorassociated neutrophils (TANs) which may polarize either towards anti-tumorigenic ‘N1’ or pro-tumorigenic ‘N2’phenotypes based on available modulators such as TGF-β and leucinedriven epigenetic modifications. The development in neutrophil biology has introduced several novel therapeutic strategies that allow NET targeting, inhibition of chemokine receptors like CXCR2, and exploration of neutrophil-derived biomarkers for diagnosis and disease monitoring. Such findings encourage the importance of neutrophils as both effectors and therapeutic targets in inflammatory and neoplastic conditions.  \nKeywords: neutrophil; neutrophil extracellular traps; autoimmune diseases; cancer; systemic lupus erythematosus; rheumatoid arthritis; juvenile idiopathic arthritis; low density neutrophils; tumor-associated neutrophils; anti-tumorigenic neutrophils; protumorigenic neutrophils  \n1. Introduction  \nNeutrophils are granulocytes, the most abundant myeloid cell type in the vascular system. Their differentiation and maturation initiate in the bone marrow before entering the blood circulation. This process is regulated through an intricate pathway via several stages of hematopoietic stem cells (HSCs) that exhibit signature gene expression. During development, three neutrophil subsets reside in bone marrow; a proliferative precursor of neutrophils named pre-neutrophils (preNeus), an intermediate neutrophil (immature Neus), and mature neutrophils population [1] . The preNeus are early-stage neutrophils that do not respond to infection and inflammation. At the same time, immature Neus enter the bloodstream late and respond to the immune response less efficiently than mature Neus. Mature neutrophils lose self-renewal ability before entering blood circulation and exhibit an immune response against infection. They also play a decisive role in excluding pathogens  \nin hosts t","cbCaikGsiP53xAdV","https://ap.wps.com/l/cbCaikGsiP53xAdV","pdf",1420491,16,"English","# Introduction\n## Neutrophil subsets and development\n## Roles in innate and adaptive immunity","[{\"question\":\"How do neutrophils contribute to autoimmune disease pathology?\",\"answer\":\"Autoimmune diseases such as SLE, RA, and JIA involve dysregulated neutrophil subsets, including low-density granulocytes that promote proinflammation and tissue damage through NETosis and type I interferon-mediated signaling.\"},{\"question\":\"What is the role of neutrophils in cancer progression?\",\"answer\":\"In tumors, tumor-associated neutrophils (TANs) can polarize toward anti-tumorigenic N1 or pro-tumorigenic N2 phenotypes, influenced by modulators such as TGF-β and leucine-driven epigenetic modifications.\"},{\"question\":\"What therapeutic directions does the neutrophil research support?\",\"answer\":\"Therapeutic strategies include targeting NETs, inhibiting chemokine receptors such as CXCR2, and using neutrophil-derived biomarkers for diagnosis and disease monitoring.\"}]","Roles of Neutrophils in Autoimmune Diseases and Cancers | PDF",1790190870,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32e49b1b1e9ea86adc85f7cb5c3c2f6b.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2d320726a9a112639fab7a94aa8cecd.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8aa0e7a46f81283c2c7088764be5f36f.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/76c4e82fe8cb8abf6b276bf2eee02a4f.webp",980,1385]